Business Description
BrightPath Biotherapeutics Co Ltd
ISIN : JP3274140007
Total Employee Number:
23Description
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.91 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 13.64 | |||||
Beneish M-Score | -3.32 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -77.6 | |||||
3-Year EBITDA Growth Rate | 22.1 | |||||
3-Year EPS without NRI Growth Rate | 22.2 | |||||
3-Year FCF Growth Rate | 15.4 | |||||
3-Year Book Growth Rate | -11.9 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.23 | |||||
9-Day RSI | 59.33 | |||||
14-Day RSI | 54.5 | |||||
3-1 Month Momentum % | -29.69 | |||||
6-1 Month Momentum % | -15.09 | |||||
12-1 Month Momentum % | -32.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 15.83 | |||||
Quick Ratio | 15.83 | |||||
Cash Ratio | 13.36 | |||||
Days Sales Outstanding | 2613.66 | |||||
Days Payable | 308.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -30.2 | |||||
Shareholder Yield % | -41.06 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.29 | |||||
Operating Margin % | -1541667.86 | |||||
Net Margin % | -1553513.1 | |||||
EBITDA Margin % | -1541667.86 | |||||
FCF Margin % | -1626716.67 | |||||
OCF Margin % | -1626013.1 | |||||
ROE % | -81.22 | |||||
ROA % | -72.18 | |||||
ROIC % | -413.96 | |||||
3-Year ROIIC % | 87.84 | |||||
ROC (Joel Greenblatt) % | -570.51 | |||||
ROCE % | -77.3 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 50000 | |||||
PB Ratio | 2.93 | |||||
Price-to-Tangible-Book | 2.93 | |||||
EV-to-EBIT | -3.7 | |||||
EV-to-EBITDA | -3.7 | |||||
EV-to-Revenue | 57004.31 | |||||
EV-to-FCF | -3.3 | |||||
Price-to-GF-Value | 10.78 | |||||
Price-to-Median-PS-Value | 75.76 | |||||
| Price-to-Net-Current-Asset-Value | 3 | |||||
| Price-to-Net-Cash | 3.62 | |||||
Earnings Yield (Greenblatt) % | -27.07 | |||||
FCF Yield % | -19.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BrightPath Biotherapeutics Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 0.084 | ||
| EPS (TTM) (円) | -11.7 | ||
| Beta | -0.2644 | ||
| 3-Year Sharpe Ratio | -0.39 | ||
| 3-Year Sortino Ratio | -0.68 | ||
| Volatility % | 82.49 | ||
| 14-Day RSI | 54.5 | ||
| 14-Day ATR (円) | 3.312596 | ||
| 20-Day SMA (円) | 46.6 | ||
| 12-1 Month Momentum % | -32.84 | ||
| 52-Week Range (円) | 43 - 114 | ||
| Shares Outstanding (Mil) | 138.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BrightPath Biotherapeutics Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BrightPath Biotherapeutics Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
BrightPath Biotherapeutics Co Ltd Frequently Asked Questions
What is BrightPath Biotherapeutics Co Ltd(TSE:4594)'s stock price today?
The current price of TSE:4594 is 円50.00. The 52 week high of TSE:4594 is 円114.00 and 52 week low is 円43.00.
When is next earnings date of BrightPath Biotherapeutics Co Ltd(TSE:4594)?
The next earnings date of BrightPath Biotherapeutics Co Ltd(TSE:4594) is .
Does BrightPath Biotherapeutics Co Ltd(TSE:4594) pay dividends? If so, how much?
BrightPath Biotherapeutics Co Ltd(TSE:4594) does not pay dividend.
Press Release
Articles on BrightPath Biotherapeutics Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers